The study, conducted by the Sherwood Forest Hospitals Foundation Trust in England, is one of the largest to examine potential vision loss and sight problems associated with thiazolidinediones. Published in The Archives of Internal Medicine, the survey involved over 103,000 people with Type 2 diabetes who were followed for approximately 10 years. Those who were using one of the medications were found to have about a two to three times higher risk of developing macular edema. Call The Herrera Law Firm San Antonio Lawyers at 1-800-455-1054 Combining the drugs with insulin, a common practice, seemed to heighten the risk further.

read The Full Story

Share this: